Table2_Association of volatile anesthesia exposure and depth with emergence agitation and delirium in children: Prospective observational cohort study.docx by Yinan Zhang (136571)

“…Taking EtSevo-time AUC ≤ 2,000 as a reference, the incidence of EA were [15.84 (2.15, 116.98) p = 0.002] times and 16.59 (2.42, 113.83) p = 0.009] times for EtSevo-time AUC 2,500–3,000 and EtSevo-time AUC > 3,000, respectively. …”

Image_1_Effects of two alveolar recruitment maneuvers in an “open-lung” approach during laparoscopy in dogs.TIFF by Caterina Di Bella (12415669)

“…</p>Results<p>Static compliance decreased in both groups at PP (ARMc = 1.35 ± 0.21; ARMi = 1.16 ± 0.26 mL/cmH₂O/kg) compared to BASE (ARMc = 1.78 ± 0.60; ARMi = 1.66 ± 0.66 mL/cmH₂O/kg) and at ARM (ARMc = 1.71 ± 0.41; ARMi = 1.44 ± 0.84 mL/cmH₂O/kg) and PostPP (ARMc = 1.75 ± 0.45; ARMi = 1.89 ± 0.59 mL/cmH₂O/kg), and it was higher compared to PP and similar to BASE. …”

Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study by Agaba Katureebe (340952)

“…The addition of three rounds of IRS at ~6-mo intervals in Nagongera was followed by clear decreases in all outcomes: incidence of malaria (3.25 pre-intervention versus 0.63 post-intervention; aRR = 0.13, 95% CI 0.07–0.27, <i>p <</i> 0.001), TPR (37.8% pre-intervention versus 15.0% post-intervention; aRR = 0.54, 95% CI 0.49–0.60, <i>p <</i> 0.001), and HBR (18.71 pre-intervention versus 3.23 post-intervention; aRR = 0.29, 95% CI 0.17–0.50, <i>p <</i> 0.001). …”

Knockdown of fatty acid binding protein 3 attenuates cerebral Ischemia-reperfusion injury <i>via</i> inhibiting neuronal apoptosis in mice by Jin-Jin Tian (22046330)

“…<p>Background: Stroke remains a leading cause of death and disability worldwide, with ischemic stroke accounting for approximately 87% of cases. …”

Trends of HIV/AIDS in Ethiopia (1990-2021). by Tegene Atamenta Kitaw (17930374)

“…Higher incidence (28.1) and mortality (17.7) were observed in females compared to males (16.7 and 9.6). The Gambela region reported the highest burden, with an incidence rate of 176.3 per 100,000, a mortality rate of 78.4 per 100,000, and 4,220.7 DALYs per 100,000.…”

Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients i... by Yashika Chugh (7325960)

“…For scenario III as compared II, QALYs increase by 0.16 (0.03 to 0.36) per person as well as costs by ₹ 3,086 per patient which ranges from a cost saving of ₹ 1,264 to incurring an extra cost of ₹ 6,344. …”

Data_Sheet_1_Characterization of Thin MAPb(I1–xBrx)3 Alloy Halide Perovskite Films Prepared by Sequential Physical Vapor Deposition.PDF by Juvet Nche Fru (10785867)

“…Analyses of dark current-voltage and capacitance-voltage curves of FTO/c-TiO₂/m-TiO₂/MAPb(I_0.11Br_0.89)₃ solar cells revealed a sizeable built-in voltage (V_bi) of 1.6 V and an accumulation of charge at interfaces for voltages greater than 0.2 V, respectively. …”

Study flow diagram. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Forest plot of LVEDD. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Data Sheet 1_Strategies for enhancing yield and quality of forage-grain dual-purpose ratoon rice: role of first-season density and nitrogen management.docx by Yuyuan Ouyang (15350374)

“…Within the studied parameters, nitrogen application had a more pronounced influence on silage quality compared to planting density. …”

Risk of bias diagram and summary. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Data_Sheet_1_Global and Historical Distribution of Clostridioides difficile in the Human Diet (1981–2019): Systematic Review and Meta-Analysis of 21886 Samples Reveal Sources of He... by Alexander Rodriguez-Palacios (8497572)

“…Across regions, the risk of CD in foods for foodborne exposure reproducibly decreased with Earth latitude (p < 0.001). In conclusion, CD in the human diet is a global non-random-source of foodborne exposure that occurs independently of laboratory culture methods, across regions, and at a variable level depending on food type and latitude. …”

Forest plot of NT-pro BNP. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Funnel plot of 6-MWT. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Forest plot of LVEF. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Forest plot of 6-MWT. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Table_1_Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation.docx by Quirino Lai (8637660)

“…Five- and 10-year recurrence rates were 16.2% and 20.3%. HCC-related deaths peaked at 2 years after LT (51.1% of all HCC-related deaths) and decreased to a high 30.8% in the interval of 6 to 10 years after LT. …”

The incidence rate of adverse events. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Basic characteristics of included studies. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”

Forest plot of LVESD. by Lipeng Shi (11307700)

“…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”